Optimi Health(NASDAQ) OPTH

Market Cap$20.04M

Since IPO (2021)-79%

5 Year-79%

1 Year-54%

1 Month-21%

$3.17

-9.57%

-0.33Today

Optimi Health last closing stock price
Metric	Price	Date
Last close	USD 3.50	2026-10-13

Optimi Health stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-15.25%	USD 4.13	2026-10-06
1 month	-20.81%	USD 4.42	2026-09-11
3 month	-26.16%	USD 4.74	2026-07-15
Year to date	-48.92%	USD 6.85	2025-12-31
1 year	-53.58%	USD 7.54	2025-10-13
3 year	-15.15%	USD 4.13	2023-10-13
5 year	-78.76%	USD 16.48	2021-10-14
Since inception	-79.25%	USD 16.87	2021-04-05

Optimi Health Financials at a Glance

Market Cap

$20.04M

Revenue (TTM)

$134.17K

Net Income (TTM)

-$6.19M

EPS (TTM)

$0.00

P/E Ratio

-3.76

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$3.17

Volume

54,633.931

Open

$3.54

Price

$3.17

Volume

54,633.931

Open

$3.54

Previous Close

$3.17

Daily Range

$3.04 - $3.54

52-Week Range

$3.04 - $8.84

Estimated Earnings Date

Feb 2, 2027

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$3.17

Volume

54,633.931

Open

$3.54

Previous Close

$3.17

Daily Range

$3.04 - $3.54

52-Week Range

$3.04 - $8.84

Estimated Earnings Date

Feb 2, 2027

OPTH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Optimi Health

Optimi Health Corp. is a Canadian company based in Princeton, focused on manufacturing pharmaceutical and nutraceutical products. Established in 2020, the company specializes in producing controlled substances, including MDMA and psilocybin, for authorized clinics and research trials.

Products and Services

Manufactures MDMA and psilocybin drug products
Offers functional mushrooms and dietary supplements
Supplies products through various distribution channels, including Amazon

Growth Outlook

Expanding product portfolio to meet increasing demand in health and wellness
Strategic partnerships with clinics and research institutions enhance market reach
Focus on innovative research to develop new therapeutic applications

Financial Highlights

Recent quarterly revenue of $98,700, showing resilience in a challenging market
Cash and cash equivalents of $9.2 million, providing operational flexibility
Trailing twelve months (TTM) gross profit margin of -20.92%, indicating potential for improvement

Optimi Health Corp. operates in the rapidly evolving healthcare sector, particularly in the field of psychedelics, which is gaining traction for its therapeutic benefits. The company's commitment to quality and innovation positions it well for future growth. With a diverse product range and strategic partnerships, Optimi Health is poised to capitalize on the increasing acceptance of psychedelic therapies. The financial metrics indicate a challenging environment, yet the substantial cash reserves provide a buffer for ongoing operations and potential expansion. Investors may find the company's focus on research and development, along with its unique product offerings, appealing as the market for psychedelics continues to mature.

AI Generated • Oct 11, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Dane Stevens

Website

www.optimihealth.ca

Headquarters

Princeton, BC V0X 1W0, CA

OPTH Financials

Key Financial Metrics (TTM)

Gross Margin

-2092.20%

Operating Margin

-3617.97%

Net Income Margin

-3927.59%

Return on Equity

-84.23%

Return on Capital

-34.18%

Return on Assets

-26.68%

Earnings Yield

-26.60%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.04M

Shares Outstanding

5.73M

Volume

54.63K

Avg. Volume

46.20K

Financials (TTM)

Gross Profit

-$938.00K

Operating Income

-$5.81M

EBITDA

-$4.36M

Operating Cash Flow

-$4.36M

Capital Expenditure

-$103.14K

Free Cash Flow

-$4.46M

Cash & ST Invst.

$9.20M

Total Debt

$3.62M

Optimi Health Performance Analysis

Optimi Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-09-30	USD 63,178	N/A
2023	2023-09-30	USD 134,260	112.5%
2024	2024-09-30	USD 286,483	113.4%
2025	2025-09-30	USD 304,907	6.4%

Optimi Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-09-30	-132.6%
Q1	2025-12-31	100.0%
Q2	2026-03-31	N/A
Q3	2026-06-30	-0.8%

Optimi Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-09-30	USD -2.21	N/A
2023	2023-09-30	USD -1.33	-40.0%
2024	2024-09-30	USD -1.49	11.9%
2025	2025-09-30	USD -0.83	-44.2%

Optimi Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-09-30	-50.0%
Q1	2025-12-31	-14.3%
Q2	2026-03-31	-2.1%
Q3	2026-06-30	20.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$98.70K

-49.7%

Gross Profit

-$298.70K

-264.2%

Gross Margin

-3.03%

N/A

Market Cap

$20.04M

N/A

Market Cap/Employee

$3.34M

N/A

Employees

N/A

Net Income

-$1.69M

-86.6%

EBITDA

-$1.34M

-134.9%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

$9.20M

+10295.7%

Total Debt

$3.62M

+26.8%

Accounts Receivable

$34.83K

-86.3%

Inventory

$206.31K

-68.7%

Long Term Debt

$95.18K

-94.9%

Short Term Debt

$3.53M

+251.7%

Return on Assets

-26.68%

N/A

Return on Invested Capital

-35.76%

N/A

Free Cash Flow

-$2.02M

-135.7%

Operating Cash Flow

-$2.01M

-134.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,709.28-0.01%

^DJIDJI

^DJIDJI$51,466.30-0.00%

^IXICNASDAQ

^IXICNASDAQ$26,684.28-0.02%

BTCBitcoin

BTCBitcoin$81,564.00-0.02%

SPCXSPCX

SPCXSPCX$152.06-0.03%

AAPLAAPL

AAPLAAPL$342.68+0.00%

AMZNAMZN

AMZNAMZN$253.61-0.02%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

BACBank of America

BACBank of America$51.39-4.76%

NVDANvidia

NVDANvidia$221.30-3.16%

CRWVCoreWeave

CRWVCoreWeave$65.78-15.46%

INTCIntel

INTCIntel$98.12-4.56%

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF$110.54-13.35%

CIFRCipher Digital

CIFRCipher Digital$9.94-12.35%

SKYDSkydance

SKYDSkydance$7.06-23.84%

Questions About OPTH

What is the current price of Optimi Health?

Optimi Health is trading at $3.17 per share.

What is the 52-week range for Optimi Health?

Over the past 52 weeks, Optimi Health has traded between $3.04 and $8.84.

How much debt does Optimi Health have?

As of the most recent reporting period, Optimi Health reported total debt of $3.63M.

How much cash does Optimi Health have on hand?

Optimi Health reported $9.21M in cash and cash equivalents in its most recent financial results.

What is Optimi Health’s dividend yield?

Optimi Health does not currently have a dividend yield.

Optimi Health(NASDAQ) OPTH

Optimi Health Financials at a Glance

OPTH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Optimi Health

OPTH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Optimi Health Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OPTH

What is the current price of Optimi Health?

What is the 52-week range for Optimi Health?

How much debt does Optimi Health have?

How much cash does Optimi Health have on hand?

What is Optimi Health’s dividend yield?

Premium Investing Services